Millogo K, Kabore B, Sondo P, Compaore E, Kouevi A, Kambou S
Acta Parasitol. 2024; 69(4):1967-1976.
PMID: 39356425
PMC: 11649751.
DOI: 10.1007/s11686-024-00923-x.
Springer E, Heimsch K, Rahlfs S, Becker K, Przyborski J
Antimicrob Agents Chemother. 2024; 68(5):e0169023.
PMID: 38501806
PMC: 11064498.
DOI: 10.1128/aac.01690-23.
Efange N, Lobe M, Yamthe L, Pekam J, Tarkang P, Ayong L
Antimicrob Agents Chemother. 2022; 66(12):e0060722.
PMID: 36409128
PMC: 9765129.
DOI: 10.1128/aac.00607-22.
Mahaman Moustapha L, Adamou R, Ibrahim M, Abdoulaye Louis Padounou M, Diallo A, Courtin D
Malar J. 2021; 20(1):1.
PMID: 33386070
PMC: 7775624.
DOI: 10.1186/s12936-020-03550-9.
Dziekan J, Wirjanata G, Dai L, Go K, Yu H, Lim Y
Nat Protoc. 2020; 15(6):1881-1921.
PMID: 32341577
DOI: 10.1038/s41596-020-0310-z.
Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against .
Birrell G, Challis M, De Paoli A, Anderson D, Devine S, Heffernan G
Mol Cell Proteomics. 2019; 19(2):308-325.
PMID: 31836637
PMC: 7000111.
DOI: 10.1074/mcp.RA119.001797.
Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity.
Huang G, Solano C, Su Y, Ezzat N, Matsui S, Huang L
Tetrahedron Lett. 2019; 60(26):1736-1740.
PMID: 31802783
PMC: 6892474.
DOI: 10.1016/j.tetlet.2019.05.054.
In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine.
Forkuo A, Ansah C, Mensah K, Annan K, Gyan B, Theron A
Malar J. 2017; 16(1):496.
PMID: 29282057
PMC: 5745596.
DOI: 10.1186/s12936-017-2142-z.
4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.
Roberts B, Zheng Y, Cleaveleand J, Lee S, Lee E, Ayong L
Int J Parasitol Drugs Drug Resist. 2017; 7(1):120-129.
PMID: 28285258
PMC: 5350499.
DOI: 10.1016/j.ijpddr.2017.02.002.
Evolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole Physiology.
Gabryszewski S, Dhingra S, Combrinck J, Lewis I, Callaghan P, Hassett M
PLoS Pathog. 2016; 12(11):e1005976.
PMID: 27832198
PMC: 5104409.
DOI: 10.1371/journal.ppat.1005976.
Spirocyclic chromanes exhibit antiplasmodial activities and inhibit all intraerythrocytic life cycle stages.
Roberts B, Iyamu I, Lee S, Lee E, Ayong L, Kyle D
Int J Parasitol Drugs Drug Resist. 2016; 6(1):85-92.
PMID: 27054067
PMC: 4805781.
DOI: 10.1016/j.ijpddr.2016.02.004.
Amino acid efflux by asexual blood-stage Plasmodium falciparum and its utility in interrogating the kinetics of hemoglobin endocytosis and catabolism in vivo.
Dalal S, Klemba M
Mol Biochem Parasitol. 2015; 201(2):116-22.
PMID: 26215764
PMC: 4568145.
DOI: 10.1016/j.molbiopara.2015.07.002.
Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.
Wilson D, Goodman C, Sleebs B, Weiss G, de Jong N, Angrisano F
BMC Biol. 2015; 13:52.
PMID: 26187647
PMC: 4506589.
DOI: 10.1186/s12915-015-0162-0.
Role and Regulation of Glutathione Metabolism in Plasmodium falciparum.
Muller S
Molecules. 2015; 20(6):10511-34.
PMID: 26060916
PMC: 6272303.
DOI: 10.3390/molecules200610511.
PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs.
van der Velden M, Rijpma S, Russel F, Sauerwein R, Koenderink J
Malar J. 2015; 14:76.
PMID: 25884516
PMC: 4350286.
DOI: 10.1186/s12936-015-0581-y.
The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death.
Qiao S, Tao S, Rojo de la Vega M, Park S, Vonderfecht A, Jacobs S
Autophagy. 2013; 9(12):2087-102.
PMID: 24113242
PMC: 3981748.
DOI: 10.4161/auto.26506.
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Wilson D, Langer C, Goodman C, McFadden G, Beeson J
Antimicrob Agents Chemother. 2013; 57(3):1455-67.
PMID: 23318799
PMC: 3591904.
DOI: 10.1128/AAC.01881-12.
Current opinion on an emergence of drug resistant strains of Plasmodium falciparum through genetic alterations.
Kasturi K, Mallika D, Amos S, Venkateshaiah P, Sambasiva Rao K
Bioinformation. 2012; 8(22):1114-8.
PMID: 23251047
PMC: 3523227.
DOI: 10.6026/97320630081114.
ATP and luciferase assays to determine the rate of drug action in in vitro cultures of Plasmodium falciparum.
Khan T, van Brummelen A, Parkinson C, Hoppe H
Malar J. 2012; 11:369.
PMID: 23134617
PMC: 3505462.
DOI: 10.1186/1475-2875-11-369.
Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy.
Jullien V, Ogutu B, Juma E, Carn G, Obonyo C, Kiechel J
Antimicrob Agents Chemother. 2010; 54(6):2611-7.
PMID: 20368402
PMC: 2876388.
DOI: 10.1128/AAC.01496-09.